PFE
PFE (NYSE) - Be CarefullGreetings
Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox).
Pra Trading :
- Please care for Money Management
- Have a good psychology
- Do not be hurry to open position and do not do nothing if u see opportunity
- Evaluate and upgrade your trading plan
Execution Strategy :
- Know what you want to buy, see the Fundamental
- Decide that you are on investing or speculating
- Consider what your strategy based on Investing/Speculating
- Make Road Map Of Your Trading Plan
- Decide
a. Entry strategy
b. Cut loss
c. Target of Profit
Post Trading :
a. Do not be sad if you loss or do not be very happy if you win
b. Just become a normal without emotion, Do not put emotion into your trading
c. Evaluate your trading
d. Keep on Learning
e. Be Humble
Idea :
PFE (NYSE) - Be Carefull
My recommended 25 stocks portfolio for 8-12 February After beating the market 4 weeks in row with compound profits of 54.14%, in 4 weeks this is my recommended portfolio of 25 stocks for the trading week 8-12 February 2021:
1- AAPL@ 136.76
2- CRSP @ 168.81
3- CSCW @ 0.9759
4- EBON @ 5.83
5- EYES @ 2.45
6- FB @ 268.10
7- FSR @ 14.99
8- GNUS @ 1.88
9- GOEV @ 17.63
10- MRIN @ 2.78
11- PAYS @ 5.16
12- PFE @ 34.92
13- PLTR @ 34.05
14- PRQR @ 5
15- PSTI @ 6.78
16- SIOX @ 3.01
17- SOLO @ 8.69
18- STAF @ 1.11
19- THMO @ 3.27
20- TLGT @ 1.02
21- TWTR @ 56.78
22- VLDR @ 23.25
23- VRM @ 46.71
24- WISA @ 3.70
25- WORX @ 2.27
Do your diligent work an always manage your risk.
Wish you a profitable week!
Moshkelgosha
Pfizer forming a double bottom to continue moving up?Another update on PFE. Price has stalled for some time now around the internal support. We have a divergence with RSI and the price and RSI is starting to move above 50. MACD is making a bullish crossing and the histogram is going positive as well. Volumes are showing buying activity and we have a potential setup for a double bottom. Keep an eye on PFE.
Ex-dividend date - An end to investors' hesitation?Good evening.
Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off.
Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says
Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February.
Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021.
P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more.
Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?
Pfizer long confirmedIn addition to the portfolio long on Pfizer will be added as the session starts. Double doji candles and MACD crossover and RSI is rising above 50 are enough as confirmation. I've been tracking PFE since the end of December and now an opportunity to buy stocks of the company has revealed. My target is $44 - $44.80.
Pfizer Analysis. 3 reasons to watch.Hello Everyone,
I hope you all had a good start to the New Year.
Pfizer (PFE) has been in the news a lot recently due to their vaccine. There may also be a few reasons to keep an eye on their stock price.
1) Support/Resistance- PFE ended the year with a pull-back. The price is currently being supported around $37. Price has hit resistance at $37 three times since May 2020. Price broke through the resistance in Nov 2020 and appears to be forming a new support in this range.
2) Fibonacci Retracement- This support/resistance area ($37) also coincides with a 61.8% retracement from the most recent low from Oct 2020 (see attached chart). Price has not closed below the 61.8% retracement as of writing.
3) MACD Divergence- Looking at the MACD/price chart, the MACD is diverging from the price. Hidden Bullish Divergence formed on the price chart/MACD at $37. This may further prove price has found a new support at $37.
I would personally like to see a close above the 50-day EMA prior to entering any trades so I will continue to watch closely.
Thank you for reading and please do your own research before trading